James Edward Hoffman, MD

Dr Gilberto Lopes is a medical oncologist and researcher who focuses on new anticancer drug development and global oncology. He has published more than 270 scientific papers and has led hundreds of clinical trials. Dr Lopes was the main investigator of Keynote 42, a clinical trial that demonstrated the efficacy of the immunotherapy drug pembrolizumab in people living with lung cancer. This groundbreaking study led to one of the FDA approvals of pembrolizumab. Additionally, Dr Lopes has contributed significantly to the development of several chemotherapies and targeted medications that address specific molecular changes in tumors.

Dr Chandhok, MD is a Hematologist and Oncologist at Sylvester Comprehensive Cancer Center. At Sylvester, Dr Chandhok works as part of a multidisciplinary team treating patients with leukemia and myelodysplastic syndrome (myeloid malignancies) . She earned her medical degree from The George Washington University School of Medicine and Health Sciences, Washington DC. †Currently seeing patients with myeloid malignancies. †Avid participant in clinical trials. †Board certified in Internal Medicine and board eligible in Hematology and Oncology. †Completed her residency in Internal Medicine at Tufts Medical Center, Boston MA †Completed her fellowship training in Hematology/ Oncology at Yale University School of Medicine, New Have...